215 related articles for article (PubMed ID: 27039776)
1. Comparison of EMA,CEA, CD10 and Bcl-2 Biomarkers by Immunohistochemistry in Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin.
Ramezani M; Mohamadzaheri E; Khazaei S; Najafi F; Vaisi-Raygani A; Rahbar M; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1379-83. PubMed ID: 27039776
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
4. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.
Beer TW; Shepherd P; Theaker JM
Histopathology; 2000 Sep; 37(3):218-23. PubMed ID: 10971697
[TBL] [Abstract][Full Text] [Related]
5. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
6. Expression Profile of CD10, BCL-2, p63, and EMA in the Normal Skin and Basal Cell Carcinomas: An Immunohistochemical Reappraisal.
Hussein MR; Ahmed AM
Actas Dermosifiliogr; 2022 Oct; 113(9):848-855. PubMed ID: 35636508
[TBL] [Abstract][Full Text] [Related]
7. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
[TBL] [Abstract][Full Text] [Related]
8. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
9. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
Abdou AG; Eldien MM; Elsakka D
Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
[TBL] [Abstract][Full Text] [Related]
10. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD10 in basal cell carcinoma.
Yada K; Kashima K; Daa T; Kitano S; Fujiwara S; Yokoyama S
Am J Dermatopathol; 2004 Dec; 26(6):463-71. PubMed ID: 15618927
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
Sabet MN; Rakhshan A; Erfani E; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
Suiqing C; Min Z; Lirong C
J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
[TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
Chang CH; Tsai RK; Chen GS; Yu HS; Chai CY
J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
16. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
17. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
Kadeh H; Saravani S; Heydari F; Shahraki S
Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
[TBL] [Abstract][Full Text] [Related]
18. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
19. CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
Wagoner J; Keehn C; Morgan MB
Am J Dermatopathol; 2007 Dec; 29(6):555-8. PubMed ID: 18032951
[TBL] [Abstract][Full Text] [Related]
20. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
